NEW YORK (GenomeWeb) – Molecular diagnostics firm Great Basin Scientific announced today that its stockholders have approved a reverse stock split of the company's shares at a ratio of one for 50 to one for 60.

The ratio and timing of the split will be decided by the company's board of directors, Great Basin said. It added that the split would cure a previously announced authorized share failure, allowing Series C warrants to be exercisable for the next 25 trading days pursuant to the amended terms of the warrants disclosed earlier this week. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.